Liness Chinyamunyamu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Liness Chinyamunyamu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Abigail Kazembe
Kamuzu University of Health Sciences
2 shared publications - Clara Sambani
Public Health Institute of Malawi
2 shared publications - Collins Mitambo
Public Health Institute of Malawi
2 shared publications - Dzinkambani Moffat Kambalame
Public Health Institute of Malawi
2 shared publications - Edna Mandala
Kamuzu University of Health Sciences
2 shared publications - Evelyn Chitsa Banda
Public Health Institute of Malawi
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 9
COVID-19 severity and vaccine effectiveness in Malawi: A test-negative case-control study
Background: COVID-19 vaccines were administered globally, and Malawi commenced vaccination on 11 March 2021. Aim: This study assessed the real-world effectiveness of COVID-19 vaccines and factors associated with disease severity and mortality in Malawi. Setting: A facility-based case-control study within the largest referral hospitals. Methods: Cases (COVID-19 positive) were matched 1:1 with controls based on age, sex and testing date. Interviews via phone focused on COVID-19 testing and vaccination, underlying conditions and disease outcomes. Analysed using STATA 17, the exposure of interest was vaccination status. For vaccine effectiveness (VE), conditional logistic regression modelling was used, while disease severity and management were analysed using binary logistic regression. Results: The unvaccinated were at 53.3%, and 35.8% were fully vaccinated and/or received a booster. The VE among the fully and partially vaccinated was 10% (95% CI: –26.2, 35.81) and 31.8% (95% CI: –9.91, 57.72), respectively compared to the unvaccinated. Most of the COVID-19 patients (87.8%) were not hospitalised. Underlying chronic conditions and a previous positive COVID-19 test were associated with severe disease (aOR: 3.54, 95% CI: 1.65, 7.61 and aOR: 2.73, 95% CI: 1.13, 7.61, respectively); however, these odds were not different by vaccination status. Conclusion: The VE was low and severe disease was linked with chronic illnesses and previous positive COVID-19 tests. Efforts to promote vaccination through education and access should be enhanced, particularly for those with underlying chronic conditions. Contribution: The findings can inform strategies on prioritisation for disease vaccination and improving patient outcomes.
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 9
Open AccessCOVID-19 severity and vaccine effectiveness in Malawi: A test-negative case-control study
Background: COVID-19 vaccines were administered globally, and Malawi commenced vaccination on 11 March 2021. Aim: This study assessed the real-world effectiveness of COVID-19 vaccines and factors associated with disease severity and mortality in Malawi. Setting: A facility-based case-control study within the largest referral hospitals. Methods: Cases (COVID-19 positive) were matched 1:1 with controls based on age, sex and testing date. Interviews via phone focused on COVID-19 testing and vaccination, underlying conditions and disease outcomes. Analysed using STATA 17, the exposure of interest was vaccination status. For vaccine effectiveness (VE), conditional logistic regression modelling was used, while disease severity and management were analysed using binary logistic regression. Results: The unvaccinated were at 53.3%, and 35.8% were fully vaccinated and/or received a booster. The VE among the fully and partially vaccinated was 10% (95% CI: –26.2, 35.81) and 31.8% (95% CI: –9.91, 57.72), respectively compared to the unvaccinated. Most of the COVID-19 patients (87.8%) were not hospitalised. Underlying chronic conditions and a previous positive COVID-19 test were associated with severe disease (aOR: 3.54, 95% CI: 1.65, 7.61 and aOR: 2.73, 95% CI: 1.13, 7.61, respectively); however, these odds were not different by vaccination status. Conclusion: The VE was low and severe disease was linked with chronic illnesses and previous positive COVID-19 tests. Efforts to promote vaccination through education and access should be enhanced, particularly for those with underlying chronic conditions. Contribution: The findings can inform strategies on prioritisation for disease vaccination and improving patient outcomes.
- Open Access
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 8
COVID-19 vaccine uptake, barriers and associated factors among healthcare workers in Malawi
Background: The COVID-19 pandemic led to an urgent need for a global vaccine. Despite being a priority group, the vaccine uptake among healthcare workers (HCWs) remains low. Aim: This article assessed the COVID-19 vaccine uptake and its associated barriers in Malawi. Setting: A cross-sectional study was conducted among HCWs in Malawi’s Blantyre, Lilongwe and Mzuzu districts from 11 April 2023 to 14 April 2023. Methods: Proportionally distributed among various cadres, 200 participants were randomly selected. A structured questionnaire was administered, assessing HCWs’ uptake, willingness, attitudes and barriers to COVID-19 vaccines. Data were managed in REDCap and analysed using STATA version 14. Frequencies and percentages were computed. Variables with p-value ≤ 0.25 were included in the multivariable modified passion model. Results: A total of 175 (88%) participants received a single-dose vaccine, while only 11.5% received a booster. Vaccine uptake was associated with age groups 25–34 years (aPR = 2.35, 95% CI: 1.21, 4.60) and 35–44 years (aPR = 2.30, 95% CI: 1.18, 4.50), being a nurse/midwife (aPR = 0.86, CI: 0.74, 0.99) and laboratory personnel (aPR = 0.86, 95% CI: 0.74, 0.99). Unvaccinated HCWs were concerned about vaccine side effects and lacked trust in the development process. Conclusion: Issues of vaccine safety, side effects and lack of trust in the vaccine should be addressed. Promoting awareness of vaccine development and benefits, targeting all age groups and cadres, is required among HCWs. Contribution: The findings can be utilised to develop specific interventions on age and cadre to promote vaccine acceptance among HCWs, in countries with similar contextual settings to Malawi.
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 8
Open AccessCOVID-19 vaccine uptake, barriers and associated factors among healthcare workers in Malawi
Background: The COVID-19 pandemic led to an urgent need for a global vaccine. Despite being a priority group, the vaccine uptake among healthcare workers (HCWs) remains low. Aim: This article assessed the COVID-19 vaccine uptake and its associated barriers in Malawi. Setting: A cross-sectional study was conducted among HCWs in Malawi’s Blantyre, Lilongwe and Mzuzu districts from 11 April 2023 to 14 April 2023. Methods: Proportionally distributed among various cadres, 200 participants were randomly selected. A structured questionnaire was administered, assessing HCWs’ uptake, willingness, attitudes and barriers to COVID-19 vaccines. Data were managed in REDCap and analysed using STATA version 14. Frequencies and percentages were computed. Variables with p-value ≤ 0.25 were included in the multivariable modified passion model. Results: A total of 175 (88%) participants received a single-dose vaccine, while only 11.5% received a booster. Vaccine uptake was associated with age groups 25–34 years (aPR = 2.35, 95% CI: 1.21, 4.60) and 35–44 years (aPR = 2.30, 95% CI: 1.18, 4.50), being a nurse/midwife (aPR = 0.86, CI: 0.74, 0.99) and laboratory personnel (aPR = 0.86, 95% CI: 0.74, 0.99). Unvaccinated HCWs were concerned about vaccine side effects and lacked trust in the development process. Conclusion: Issues of vaccine safety, side effects and lack of trust in the vaccine should be addressed. Promoting awareness of vaccine development and benefits, targeting all age groups and cadres, is required among HCWs. Contribution: The findings can be utilised to develop specific interventions on age and cadre to promote vaccine acceptance among HCWs, in countries with similar contextual settings to Malawi.